Ratings Generali

Equities

G

IT0000062072

Market Closed - Borsa Italiana 11:44:59 2024-07-18 am EDT Pre-market 02:07:22 am
23.55 EUR 0.00% Intraday chart for Generali 23.62 +0.32%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

  • With a P/E ratio at 9.57 for the current year and 8.79 for next year, earnings multiples are highly attractive compared with competitors.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.85 for the current period. Therefore, the company is undervalued.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's earnings growth outlook lacks momentum and is a weakness.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
+23.27% 39.64B
B
+9.36% 77.43B
B-
+14.00% 53.61B
B+
+14.29% 53.58B
B
+22.40% 46.7B
B+
+20.82% 44.99B
B+
+25.36% 35.46B
B
+40.33% 28.8B
A
-0.23% 28.95B
B
-6.84% 27.81B
B-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes